|Product Overview:||Recombinant Human CHRDL1(Glu22~Cys450) fused with His tag at N-terminal was expressed in E. coli.|
|Description:||This gene encodes an antagonist of bone morphogenetic protein 4. The encoded protein may play a role in topographic retinotectal projection and in the regulation of retinal angiogenesis in response to hypoxia. Alternatively spliced transcript variants encoding different isoforms have been described.|
|Form:||PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.|
|Endotoxin:||<1.0EU per 1µg (determined by the LAL method)|
|Applications:||Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
|Stability:||The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 centigrade for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.|
|Storage:||Avoid repeated freeze/thaw cycles. Store at 2-8 centigrade for one month. Aliquot and store at -80 centigrade for 12 months.|
|Reconstitution:||Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.|
|Gene Name:||CHRDL1 chordin-like 1 [ Homo sapiens ]|
|Synonyms:||CHRDL1; chordin-like 1; chordin-like protein 1; CHL; NRLN1; neuralin 1; neuralin-1; ventroptin; neurogenesin-1; VOPT; dA141H5.1;|
Price does not include shipping and packaging costs.Request quote for final price.